Company news
Chiome Bioscience Inc. news in 2021
Chiome Bioscience Inc.'s news releases, calls and decks from 2021, newest first.
Move to the second half part of Phase 1 clinical trial of first-in-class CBA-1205
December 24, 2021
Supplement Documents for Financial Results Q3 FY12/21
November 12, 2021
Non-Consolidated Financial Results (Japanese GAAP) for the Nine Months Ended September 30, 2021
November 12, 2021
Supplement Documents for Financial Results Q2 FY12/21
August 13, 2021
Non-Consolidated Financial Results (Japanese GAAP) for the Six Months Ended June 30, 2021
August 13, 2021
Termination of Collaborative Development License and Exclusive Option Agreement for anti-Semaphorin 3A antibody
May 14, 2021
Non-Consolidated Financial Results (Japanese GAAP) for the Three Months Ended March 31,2021
May 14, 2021
Supplement Documents for Financial Results Q1 FY12/21
May 14, 2021
Collaborative Research Agreement with Mologic Ltd. for antibody discovery and development
May 14, 2021